NORDIC BIOTECH GENERAL PARTNER ApS: Financial statements 2016
CVR: 26270367
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
NORDIC BIOTECH GENERAL PARTNER ApS (CVR 26270367) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 16,250 and a net result of DKK 11,467 compared with DKK 12,596 the year before. That is a decrease of 7.1% compared with the year before. Equity in the 2016 report amounted to DKK 281,397. The solvency ratio was 89.8%.
- Gross Profit
- DKK 16,250
- Profit/Loss
- DKK 11,467
- Equity
- DKK 281,397
- Total Assets
- DKK 313,500
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 16 t. | 11 t. | 281 t. | - |
| 2015 | - | 18 t. | 13 t. | 270 t. | - |
| 2014 | - | 21 t. | 15 t. | 257 t. | - |
| 2013 | - | 22 t. | 16 t. | 242 t. | - |
| 2012 | - | 21 t. | 15 t. | 226 t. | - |
Official annual report
Find more companies like NORDIC BIOTECH GENERAL PARTNER ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
NORDIC BIOTECH GENERAL PARTNER ApS has published its annual report for 2015. Gross profit came to DKK 17,500, and the net result was DKK 12,596.
About NORDIC BIOTECH GENERAL PARTNER ApS
NORDIC BIOTECH GENERAL PARTNER ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS and C. HANSEN INVEST ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 163,699 and a net result of DKK 178,169 compared with DKK 67,346 the year before. Equity in the 2025 report amounted to DKK 1,214,065.